Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan.

scientific article

Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1537-2995.2004.03300.X
P698PubMed publication ID15157263

P50authorShunji MishiroQ45614514
P2093author name stringNaokazu Takeda
Hisami Ikeda
Kanji Fukai
Shinichiro Sato
Toshiaki Kato
Kazuaki Takahashi
Keiji Matsubayashi
Hidekatsu Sakata
Yasuhiro Nagaoka
Mitsunobu Imai
P2860cites workAnalysis of HBV infection after blood transfusion in Japan through investigation of a comprehensive donor specimen repositoryQ43581611
Seroprevalence of known and putative hepatitis markers in United States blood donors with ALT levels at least 120 IU per L.Q43635344
A case report: two patients with fulminant hepatitis E in Hokkaido, Japan.Q43713352
Hepatitis E virus transmission to a volunteerQ44391700
Empty virus-like particle-based enzyme-linked immunosorbent assay for antibodies to hepatitis E virusQ44502533
Identification of a novel variant of hepatitis E virus in Austria: sequence, phylogenetic and serological analysisQ45739648
Identification of 2 novel isolates of hepatitis E virus in ArgentinaQ45741677
Hepatitis E virus: can it be transmitted parenterally?Q45745557
Vertical transmission of hepatitis E virusQ45786178
Trends in residual risk of transfusion-transmitted viral infections in France between 1992 and 2000.Q55239686
Sporadic Hepatitis E in AustriaQ56786160
Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in JapanQ34196037
A novel virus in swine is closely related to the human hepatitis E virusQ34437217
Evidence that rodents are a reservoir of hepatitis E virus for humans in NepalQ34989483
Zoonotic transmission of hepatitis E virus from deer to human beingsQ40569571
Swine hepatitis E virus strains in Japan form four phylogenetic clusters comparable with those of Japanese isolates of human hepatitis E virusQ42595601
Characterization of Japanese swine and human hepatitis E virus isolates of genotype IV with 99 % identity over the entire genomeQ42597074
Full-genome nucleotide sequence of a hepatitis E virus strain that may be indigenous to JapanQ42656890
Genetic heterogeneity of hepatitis E virusQ42658572
Analysis of the complete genome of indigenous swine hepatitis E virus isolated in JapanQ42665298
The sequence and phylogenetic analysis of a novel hepatitis E virus isolated from a patient with acute hepatitis reported in the United StatesQ42674645
Genetic heterogeneity of hepatitis E virus recovered from Japanese patients with acute sporadic hepatitis.Q42676018
Prevalence, isolation, and partial sequence analysis of hepatitis E virus from domestic animals in ChinaQ42680283
Identification of two distinct genotypes of hepatitis E virus in a Japanese patient with acute hepatitis who had not travelled abroadQ42680607
Identification of a novel strain of hepatitis E virus responsible for sporadic acute hepatitis in TaiwanQ42680751
Novel hepatitis E virus (HEV) isolates from Europe: evidence for additional genotypes of HEV.Q42692392
Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor populationQ43040535
P433issue6
P921main subjectJapanQ17
hepatitis EQ326643
hepatitis E virusQ5731737
P304page(s)934-940
P577publication date2004-06-01
P1433published inTransfusionQ15758500
P1476titleTransfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan
P478volume44

Reverse relations

cites work (P2860)
Q36540997A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis E in Liver Transplant Recipients in Japan.
Q44598882A nationwide survey of hepatitis E virus (HEV) infection in wild boars in Japan: identification of boar HEV strains of genotypes 3 and 4 and unrecognized genotypes
Q28069291Acute Hepatitis E: Two Sides of the Same Coin
Q41722246Assessment of a transfusion emergent risk: the case of HEV
Q37630325Autochthonous hepatitis e virus infections: a new transfusion-associated risk?
Q27646563Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure
Q40578368Chronic hepatitis E - an emerging disease in an immunocompromised host
Q40000466Chronic hepatitis E virus infection after living donor liver transplantation via blood transfusion: a case report
Q36417563Chronic hepatitis e infection resulting in graft failure in a liver transplant tourist
Q33961593Cirrhosis, liver transplantation and HIV infection are risk factors associated with hepatitis E virus infection
Q42198637Clinical and molecular analyses of sporadic acute hepatitis A and E and the specific viral genotypes isolated in Iwate and three neighboring prefectures in the northern part of Honshu, Japan, between 2004 and 2013.
Q37394249Comparative pathogenesis in specific-pathogen-free chickens of two strains of avian hepatitis E virus recovered from a chicken with Hepatitis-Splenomegaly syndrome and from a clinically healthy chicken
Q33703351Comparison of real-time PCR and antigen assays for detection of hepatitis E virus in blood donors
Q38056078Culture systems for hepatitis E virus
Q35690082Detection of hepatitis E virus-specific immunoglobulin a in patients infected with hepatitis E virus genotype 1 or 3
Q34164503Discovery of hepatitis E: the epidemic non-A, non-B hepatitis 30 years down the memory lane.
Q35991946Economics of pathogen inactivation technology for platelet concentrates in Japan
Q37835780Efficient cell culture systems for hepatitis E virus strains in feces and circulating blood.
Q40330567Emergent viral threats in blood transfusion
Q34068582Epidemiology of hepatitis e virus infection in patients on chronic hemodialysis
Q38396830Expression and characterization of hepatitis E virus-like particles and non-virus-like particles from insect cells
Q45361732Fatal course of an autochthonous hepatitis E virus infection in a patient with leukemia in Germany
Q38110609Features of hepatitis E virus infection in humans and animals in Japan
Q92164533Genetic Variability and Evolution of Hepatitis E Virus
Q40130228HEV and transfusion-recipient risk
Q36805354Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran
Q56656388Hepatitis E
Q56915346Hepatitis E Virus
Q56995087Hepatitis E Virus
Q56995125Hepatitis E Virus
Q36811948Hepatitis E Virus (HEV) Genotype 3 Infection of Human Liver Chimeric Mice as a Model for Chronic HEV Infection
Q33769640Hepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation.
Q35758900Hepatitis E Virus in Cambodia: Prevalence among the General Population and Complete Genome Sequence of Genotype 4
Q91715099Hepatitis E and Allogeneic Hematopoietic Stem Cell Transplantation: A French Nationwide SFGM-TC Retrospective Study
Q40601448Hepatitis E viral loads in plasma pools for fractionation
Q38612287Hepatitis E virus RNA in Australian blood donors: prevalence and risk assessment.
Q26751267Hepatitis E virus as an emerging zoonotic pathogen
Q37098206Hepatitis E virus in developed countries: one of the most successful zoonotic viral diseases in human history?
Q38538122Hepatitis E virus in the countries of the Middle East and North Africa region: an awareness of an infectious threat to blood safety
Q37544935Hepatitis E virus infection
Q43347427Hepatitis E virus infection in Ghanaian blood donors - the importance of immunoassay selection and confirmation.
Q37858676Hepatitis E virus infection in developed countries
Q42274833Hepatitis E virus infection in patients infected with human immunodeficiency virus in an endemic area in Iran
Q33739483Hepatitis E virus infections in travellers: assessing the threat to the Australian blood supply
Q38902776Hepatitis E virus seroprevalence among hemodialysis and hemophiliac patients in Tunisia (North Africa).
Q42246567Hepatitis E virus seroprevalence and molecular study among blood donors in China
Q45347479Hepatitis E virus seroprevalence before hematopoietic SCT: a pediatric experience
Q45325570Hepatitis E virus subtype 3f strains isolated from Japanese hepatitis patients with no history of travel to endemic areas - The origin analyzed by molecular evolution.
Q41722255Hepatitis E virus: Blood transfusion implications
Q40967079Hepatitis E virus: seroprevalence and frequency of viral RNA detection among US blood donors
Q36487807Hepatitis E: An Underdiagnosed, Emerging Infection in Nonendemic Regions.
Q28079743Hepatitis E: Discovery, global impact, control and cure
Q34264481Hepatitis E: a complex and global disease
Q38582155Hepatitis E: an emerging global disease - from discovery towards control and cure
Q37320904Hepatitis E: an emerging infection in developed countries.
Q35049128Hepatitis E: an old infection with new implications.
Q38137898Hepatitis E: current status.
Q38839954Hepatitis E: latest developments in knowledge.
Q38192527Hepatitis e virus: current concepts and future perspectives
Q42264440High genomic similarity between European type hepatitis E virus subgenotype 3e strains isolated from an acute hepatitis patient and a wild boar in Mie, Japan.
Q37544940Host immune status and response to hepatitis E virus infection.
Q92142831Identification of hepatitis E virus subtype 4f in blood donors in Shanghai, China
Q40331422Incidence and duration of hepatitis E virus infection in Dutch blood donors
Q37038794Incidence of Hepatitis E Virus Infection in Recipients of Blood or Blood Products Transfusion
Q35991941Infectious risks associated with the transfusion of blood components and pathogen inactivation in Japan
Q34232824Infectious swine hepatitis E virus is present in pig manure storage facilities on United States farms, but evidence of water contamination is lacking
Q40507410Laboratory Diagnosis of HEV Infection
Q40122194New viral risks in blood transfusion by 2016
Q36171437Novel approach for detection of hepatitis E virus infection in German blood donors
Q45396822Prevalence of hepatitis E virus IgG antibody in Japanese patients with hemophilia
Q45406183Prevalence of hepatitis E virus among wild boar in the Ehime area of western Japan.
Q40390537Prevalence of hepatitis E virus infection among blood donors in mainland China: a meta-analysis
Q44807693Prevalence of nucleic acid sequences specific for human parvoviruses, hepatitis A and hepatitis E viruses in coagulation factor concentrates
Q50767714Prevention of transfusion-transmitted hepatitis E by donor-initiated self exclusion.
Q77791813Probable transmission of hepatitis E virus (HEV) via transfusion in the United States
Q45410039Quantitative detection of hepatitis E virus RNA and dynamics of viral replication in experimental infection
Q42205129Rare case of transfusion-transmitted hepatitis E from the blood of a donor infected with the hepatitis E virus genotype 3 indigenous to Japan: Viral dynamics from onset to recovery
Q45325825Re: Epidemiology of hepatitis E virus in children
Q48012815Red blood cell transfusion-transmitted acute hepatitis E in an immunocompetent subject in Europe: a case report
Q40078243Risk Factors Associated with Blood Exposure for Sporadic Hepatitis E in Dhaka, Bangladesh
Q91686637Risk assessment for hepatitis E virus infection from domestic pigs introduced into an experimental animal facility in a medical school
Q38268414Risk factors for hepatitis E virus infection and disease.
Q33415330Serological and molecular evidence of a plausible transmission of hepatitis E virus through pooled plasma
Q28652630Seroprevalence and Incidence of hepatitis E in blood donors in Upper Austria
Q40055954Seroprevalence and incidence of hepatitis E virus among blood donors: A review
Q38398009Seroprevalence and incidence of hepatitis E virus infection in German blood donors
Q35582431Seroprevalence of hepatitis E among Iranian renal transplant recipients
Q41658138Seroprevalence of hepatitis E virus (HEV) and detection of HEV RNA with a transcription-mediated amplification assay in blood donors from Catalonia (Spain).
Q91650627Seroprevalence of viral hepatitis A, B, C, D and E viruses in the Hormozgan province southern Iran
Q59745217Significance of hepatitis E virus infection in HIV-infected patients: a challenging issue
Q44761065Sporadic acute hepatitis E occurred constantly during the last decade in northeast Japan
Q35067078Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance
Q38962794The association of elevated alanine aminotransferase levels with hepatitis E virus infections among blood donors in China
Q37960564The epidemiology of hepatitis E virus infections in developed countries and among immunocompromised patients.
Q37877930The molecular epidemiology of hepatitis E virus infection
Q34982710Three amino acid mutations (F51L, T59A, and S390L) in the capsid protein of the hepatitis E virus collectively contribute to virus attenuation
Q49953709Transfusion-Transmitted Hepatitis E: NAT Screening of Blood Donations and Infectious Dose.
Q43220367Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country.
Q41960338Transfusion-transmitted hepatitis E in a patient with myelodysplastic syndromes
Q27480405Transfusion-transmitted infections
Q52358472Transmission and Epidemiology of Hepatitis E Virus Genotype 3 and 4 Infections.
Q40542632Transmission of Hepatitis E Virus
Q28066465Transmission of Hepatitis E Virus in Developing Countries
Q45348271Transmission of hepatitis E virus by transfusion: what is the risk?
Q40350849Unique clinical courses of transfusion-transmitted hepatitis E in patients with immunosuppression
Q36825509World Health Organization International Standard to harmonize assays for detection of hepatitis E virus RNA.
Q90743519[Risk of transmission of blood-derived pathogens by transfusion in Poland]

Search more.